Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study)

被引：7
作者：
Puleo, Christopher W. [1 ]
Ayers, Colby R. [2 ]
Garg, Sonia [2 ]
Neeland, Ian J. [2 ]
Lewis, Alana A. [2 ]
Pandey, Ambarish [2 ]
Drazner, Mark H. [2 ]
de Lemos, James A. [2 ]
机构：
[1] Ochsner Med Ctr, Heart & Vasc Inst, 1514 Jefferson Highway, New Orleans, LA 70121 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Div Cardiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
来源：
BIOMARKERS IN MEDICINE | 2021年 / 15卷 / 16期
关键词：
biostatistics; cardiology; heart failure; NATRIURETIC PEPTIDE LEVELS; LEFT-VENTRICULAR HYPERTROPHY; C-REACTIVE PROTEIN; ATHEROSCLEROSIS RISK; GENERAL-POPULATION; PROGNOSTIC VALUE; IMPACT; ASSAY; MORTALITY; FAILURE;
D O I：
10.2217/bmm-2021-0055
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Aim: N-terminal pro-B-type natriuretic peptide (NT-proBNP) and high-sensitivity cardiac troponin T (hs-cTnT) associate with structural heart disease and heart failure risk in individuals without known cardiovascular disease (CVD). However, few data are available regarding whether factors influencing levels of these two biomarkers are similar or distinct. We performed serial measurement of NT-proBNP and hs-cTnT in a contemporary multiethnic cohort with extensive phenotyping, with the goal of identifying their respective biological determinants in a population without known or suspected CVD. Methods: We evaluated 1877 participants of the Dallas Heart Study who had NT-proBNP and hs-cTnT measured and were free from clinical CVD at the each of its two examinations (2000-2002 and 2007-2009). Variables collected included demographic and risk factors, high-sensitivity C-reactive protein, body composition via dual-energy x-ray absorptiometry, coronary artery calcium by computed tomography, and cardiac dimensions and function by cardiac MRI. Linear regression was used to identify associations of these factors with each biomarker at baseline and with changes in biomarkers over follow-up. Results: NT-proBNP and hs-cTnT were poorly correlated at baseline (Spearman rho 0.083, p = 0.015), with only moderate correlation between change values (rho 0.18, p < 0.001). hs-cTnT positively associated and NT-proBNP inversely associated with male gender and black race. At baseline, both NT-proBNP and hs-cTnT associated with left ventricular end-diastolic volume and wall thickness, but only NT-proBNP associated with left atrial size. Changes in cardiac dimensions between phases were more strongly associated with changes in NT-proBNP than hs-cTnT. NT-proBNP was more strongly associated with high-sensitivity C-reactive protein and measures of body composition than hs-cTnT. Conclusion: Among individuals without CVD in the general population, NT-proBNP and hs-cTnT are nonredundant biomarkers that are differentially associated with demographic and cardiac factors. These findings indicate that hs-cTnT and NT-proBNP may reflect different pathophysiological pathways.
引用
收藏
页码：1487 / 1498
页数：12
相关论文
共 40 条
[1]   Relation of coronary atherosclerosis determined by election beam computed tomography and plasma levels of N-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (The Dallas Heart Study) [J].
Abdullah, SM ;
Khera, A ;
Das, SR ;
Stanek, HG ;
Canham, RM ;
Chung, AK ;
Morrow, DA ;
Drazner, MH ;
McGuire, DK ;
de Lemos, JA .
AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (09) :1284-1289
[2]   Prediction of Incident Heart Failure in General Practice The Atherosclerosis Risk in Communities (ARIC) Study [J].
Agarwal, Sunil K. ;
Chambless, Lloyd E. ;
Ballantyne, Christie M. ;
Astor, Brad ;
Bertoni, Alain G. ;
Chang, Patricia P. ;
Folsom, Aaron R. ;
He, Max ;
Hoogeveen, Ron C. ;
Ni, Hanyu ;
Quibrera, Pedro M. ;
Rosamond, Wayne D. ;
Russell, Stuart D. ;
Shahar, Eyal ;
Heiss, Gerardo .
CIRCULATION-HEART FAILURE, 2012, 5 (04) :422-429
[3]   Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction [J].
Aviles, RJ ;
Askari, AT ;
Lindahl, B ;
Wallentin, L ;
Jia, G ;
Ohman, EM ;
Mahaffey, KW ;
Newby, LK ;
Califf, RM ;
Simoons, ML ;
Topol, EJ ;
Lauer, MS ;
Berger, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (26) :2047-2052
[4]   Troponin I and cardiovascular risk prediction in the general population: the BiomarCaRE consortium [J].
Blankenberg, Stefan ;
Salomaa, Veikko ;
Makarova, Nataliya ;
Ojeda, Francisco ;
Wild, Philipp ;
Lackner, Karl J. ;
Jorgensen, Torben ;
Thorand, Barbara ;
Peters, Annette ;
Nauck, Matthias ;
Petersmann, Astrid ;
Vartiainen, Erkki ;
Veronesi, Giovanni ;
Brambilla, Paolo ;
Costanzo, Simona ;
Iacoviello, Licia ;
Linden, Gerard ;
Yarnell, John ;
Patterson, Christopher C. ;
Everett, Brendan M. ;
Ridker, Paul M. ;
Kontto, Jukka ;
Schnabel, Renate B. ;
Koenig, Wolfgang ;
Kee, Frank ;
Zeller, Tanja ;
Kuulasmaa, Kari .
EUROPEAN HEART JOURNAL, 2016, 37 (30) :2428-+
[5]   Medical progress - Coronary microvascular dysfunction [J].
Camici, Paolo G. ;
Crea, Filippo .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (08) :830-840
[6]   Temporal Changes in Body Fat Distribution and Hypertension [J].
Chandra, Alvin ;
Ayers, Colby R. ;
Neeland, Ian J. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (25) :3357-3359
[7]   Utility of Traditional Circulating and Imaging-Based Cardiac Biomarkers in Patients with Predialysis CKD [J].
Colbert, Gates ;
Jain, Nishank ;
de Lemos, James A. ;
Hedayati, S. Susan .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2015, 10 (03) :515-529
[8]   Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA) [J].
Daniels, Lori B. ;
Clopton, Paul ;
deFilippi, Christopher R. ;
Sanchez, Otto A. ;
Bahrami, Hossein ;
Lima, Joao A. C. ;
Tracy, Russell P. ;
Siscovick, David ;
Bertoni, Alain G. ;
Greenland, Philip ;
Cushman, Mary ;
Maisel, Alan S. ;
Criqui, Michael H. .
AMERICAN HEART JOURNAL, 2015, 170 (06) :1170-1183
[9]   Impact of body mass and body composition on circulating levels of natriuretic peptides - Results from the Dallas heart study [J].
Das, SR ;
Drazner, MH ;
Dries, DL ;
Vega, GL ;
Stanek, HG ;
Abdullah, SM ;
Canham, RM ;
Chung, AK ;
Leonard, D ;
Wians, FH ;
de Lemos, JA .
CIRCULATION, 2005, 112 (14) :2163-2168
[10]   Multimodality Strategy for Cardiovascular Risk Assessment Performance in 2 Population-Based Cohorts [J].
de Lemos, James A. ;
Ayers, Colby R. ;
Levine, Benjamin ;
deFilippi, Christopher R. ;
Wang, Thomas J. ;
Hundley, W. Gregory ;
Berry, Jarett D. ;
Seliger, Stephen L. ;
McGuire, Darren K. ;
Ouyang, Pamela ;
Drazner, Mark H. ;
Budoff, Matthew ;
Greenland, Philip ;
Ballantyne, Christie M. ;
Khera, Amit .
CIRCULATION, 2017, 135 (22) :2119-+
1234